Inotersen Treatment for Patients with Hereditary Transthyretin Amyloidosis

Journal Title: Turkish Journal of Neurology - Year 2019, Vol 25, Issue 1

Abstract

no summary

Authors and Affiliations

Faruk Uğur Doğan, Murat Kürtüncü

Keywords

Related Articles

Transient Encephalopathy with A Single Dose of Oral Metronidazole: A Case Report

Metronidazole (MNZ) is an antibacterial agent widely used in the treatment of anaerobic and protozoal infections, easily penetrating the cerebrospinal fluid and central nervous system. MNZ is well-tolerated, but it can a...

Correlation of Prechtl Qualitative Assessment of General Movement Analysis with Neurological Evaluation: The Importance of Inspection in Infants

Objective: Motor development is at the forefront of evaluation of neurodevelopmental functions in the first 6 months of life. Significant spontaneous movement patterns of infants are called general movements. General mov...

Neurofibromatosis Type 1-related Multiple Plexiform Neurofibromas: A Case Report

Neurofibromatosis type 1 (NF1) and type 2 (NF2) are autosomal dominant diseases. Patients with NF1 or NF2 have the potential to develop benign and malignant tumors. We present a 17-year-old patient with undiagnosed NF1-r...

Diagnosis and Treatment in Vestibular Migraine

Vestibular migraine (VM) is the most common cause of recurrent spontaneous vertigo. Inclusion of the diagnostic criteria for VM in the last edition of the International Classification of Headache Disorders published in 2...

Download PDF file
  • EP ID EP50329
  • DOI 10.4274/tnd.galenos.2019.57224
  • Views 219
  • Downloads 0

How To Cite

Faruk Uğur Doğan, Murat Kürtüncü (2019). Inotersen Treatment for Patients with Hereditary Transthyretin Amyloidosis. Turkish Journal of Neurology, 25(1), -. https://europub.co.uk/articles/-A-50329